Post Test and Evaluation for "What's New in Women's Health in Primary Care CE" (Virtual)
Dr. Todd Carter presents "Pharmacology Update: What's New for Women in Primary Care Practice." This continuing education session will allow you to discuss changes in current medications prescribed for women in primary care, distinguish pertinent pharmacokinetics for current medications used in the primary care of women and interpret clinical applications for current medications used in the primary care of women.

“This activity is approved for 3.0 contact hour(s) of continuing education (which includes 3.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 16102372. This activity was planned in accordance with AANP CE Standards and Policies.”

Email address *
First Name *
1 point
Your answer
Last Name *
1 point
Your answer
Discipline (Pick at least one) *
1 point
Required
Which of the following describes you? *
1 point
Required
1. Which of the following categories is new to the Pregnancy and Lactation Labeling Rule? *
1 point
2. Addyi has a major interaction with ______ leading it to be involved in the R.E.M.S. program. *
1 point
3. Osphena no longer requires a black box warning concerning the use of unopposed estrogen *
1 point
4. Addyi can be taken PRN for sexual desire earning it the nickname “The Female Viagra” *
1 point
5. Which of the following drugs discussed for use in Women’s health has seen abuse potential in recent years? *
1 point
6. Concerning the new PLLR , information about the existence of any pregnancy registries in drug labeling has been recommended but not required until now. *
1 point
7. Brisdelle is the only non-hormonal, prescription treatment option proven to reduce moderate to severe hot flashes during menopause so they are less frequent and less intense. The active ingredient in Brisdelle is the same as in which other drug? *
1 point
8. According to the PLLR prescription drugs and biologic products submitted after June 30, 2015, will use the new format immediately, while labeling for prescription drugs approved on or after June 30, 2001, will be_____ *
1 point
10. Which of the following pharmacologic agents is indicated for Hypo-active sexual desire disorder (HSDD)? *
1 point
11. As a result of my participation in this activity, I am better able to discuss changes in current medications prescribed for women in primary care. *
1 point
Strongly Agree
Strongly Disagree
12. As a result of my participation in this activity, I am better able to distinguish pertinent pharmacokinetics for current medications used in the primary care of women. *
1 point
Strongly Agree
Strongly Disagree
13. As a result of my participation in this activity, I am better able to interpret clinical applications for current medications used in the primary care of women. *
1 point
Strongly Agree
Strongly Disagree
14. The teaching methods used were appropriate to the objectives. *
1 point
Strongly Agree
Strongly Disagree
15. The speaker demonstrated experiential knowledge of the topic. *
1 point
Strongly Agree
Strongly Disagree
16. The individual objectives/content topics were cohesive with one another. *
1 point
Strongly Agree
Strongly Disagree
17. The content provided a fair and balanced coverage of the topic. *
1 point
Strongly Agree
Strongly Disagree
18. Speaker(s) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation. *
1 point
Strongly Agree
Strongly Disagree
19. The content was free of commercial bias. *
1 point
Strongly Agree
Strongly Disagree
20. I would recommend this program to my colleagues. *
1 point
Strongly Agree
Strongly Disagree
21. This activity enhanced my current knowledge base. *
1 point
Strongly Agree
Strongly Disagree
22. What, if any, recommendations would you like to share for future improvement of this program? *
1 point
Your answer
This program has been sponsored by the Frontier Nursing University Alumni Association
Submit
Never submit passwords through Google Forms.
This form was created inside of Frontier Nursing University. Report Abuse - Terms of Service